Single and Dual Chamber Leadless Pacemaker Systems, only from Abbott
.png)
For the first time ever, see how Single Chamber Atrial Leadless Pacing can help patients with:
Explore Single Chamber Ventricular Leadless Pacing for patients with:
Redefine the patient experience using a Dual Chamber Leadless Pacing solutions for patients living with:
Patient therapy can be tailored by implanting an atrial or ventricular device alone, or both combined for dual chamber support. The option to upgrade over time allows you to meet your patient’s needs today and adapt to common disease progression later.
Option to Start With Ventricular Pacing
Treat patients for rare intermittent A-V block today.
Add Atrial Pacing Later
Treat those same patients by adding an atrial device if sick sinus syndrome develops later to provide DDDR therapy.
Achieve Dual Chamber Pacing
Now you have options to adapt to patient needs over time.
With sensing and pacing in both the right atrium and right ventricle, you now have AAI, VVI, and DDD leadless configurations to consider. You can match your patient's pacing needs today and then upgrade over time as those needs change.
To support the dual chamber therapy, each implant communicates beat-to-beat with a paired, co-implanted device using implant-to-implant (i2i) communication. This novel technology employs low energy, subthreshold pulses between implanted devices using the conductive nature of the body's blood pool and myocardial tissue. These high frequency pulses of data are delivered concurrently with each locally paced or sensed event, without impact on pacing or intrinsic sensing.
This allows for the replacement of the atrial or ventricular device at end of service (EOS) without leaving hardware behind.
Specialty designed retrieval catheter supported by step-by-step protocol.
Through nine years regardless of implant duration, AVEIR VR™ predicate device has a long-term retrieval success rate above 88%.3
Active fixation helix uses a screw-in mechanism to enable both implantation and long-term retrieval of the leadless pacemaker.
AVEIR VR and AVEIR AR Leadless Pacemakers can measure R-waves, impedance, and an initial capture threshold before fixation by simply touching the electrode to the endocardial tissue.1,4 AVEIR VR and AVEIR AR Leadless Pacemakers are engaged with a rotational motion into the endocardium.
AVEIR VR and AVEIR AR Leadless Pacemakers' mapping capability is designed to help reduce the number of repositioning attempts.1,4
References
MAT-2306873 v3.0